Acadian Asset Management’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Sell |
1,237,113
-43,418
| -3% | -$12.8K | ﹤0.01% | 1204 |
|
|
2025
Q1 | $389K | Buy |
1,280,531
+1,056,047
| +470% | +$321K | ﹤0.01% | 1123 |
|
|
2024
Q4 | $644K | Buy |
224,484
+40,821
| +22% | +$117K | ﹤0.01% | 1016 |
|
|
2024
Q3 | $470K | Sell |
183,663
-72,992
| -28% | -$187K | ﹤0.01% | 1106 |
|
|
2024
Q2 | $501K | Sell |
256,655
-25,758
| -9% | -$50.3K | ﹤0.01% | 1194 |
|
|
2024
Q1 | $750K | Buy |
282,413
+219,563
| +349% | +$583K | ﹤0.01% | 923 |
|
|
2023
Q4 | $258K | Buy |
+62,850
| New | +$258K | ﹤0.01% | 1180 |
|
|
2023
Q1 | – | Sell |
-4,545
| Closed | -$20K | – | 1863 |
|
|
2022
Q4 | $20K | Buy |
+4,545
| New | +$20K | ﹤0.01% | 1712 |
|
|
2021
Q2 | – | Sell |
-10,832
| Closed | -$206K | – | 2120 |
|
|
2021
Q1 | $206K | Sell |
10,832
-1,560
| -13% | -$29.7K | ﹤0.01% | 1494 |
|
|
2020
Q4 | $278K | Buy |
+12,392
| New | +$278K | ﹤0.01% | 1430 |
|